SCATENA, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 721
EU - Europa 239
AS - Asia 124
AF - Africa 24
Totale 1.108
Nazione #
US - Stati Uniti d'America 703
CN - Cina 68
IT - Italia 55
SE - Svezia 55
BG - Bulgaria 30
SG - Singapore 27
AT - Austria 26
GB - Regno Unito 22
CA - Canada 16
DE - Germania 15
VN - Vietnam 14
CI - Costa d'Avorio 13
RU - Federazione Russa 10
FI - Finlandia 8
SN - Senegal 8
TR - Turchia 7
UA - Ucraina 5
ES - Italia 4
JP - Giappone 4
BE - Belgio 3
NG - Nigeria 3
CZ - Repubblica Ceca 2
KR - Corea 2
PL - Polonia 2
BZ - Belize 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
MX - Messico 1
RO - Romania 1
Totale 1.108
Città #
Woodbridge 96
Houston 88
Ann Arbor 85
Chandler 73
Fairfield 66
Sofia 30
Ashburn 25
Vienna 25
New York 22
Seattle 22
Cambridge 21
Beijing 20
Princeton 19
Wilmington 16
Lancaster 14
Abidjan 13
Dearborn 13
Ottawa 13
Santa Clara 12
Boardman 11
Des Moines 11
Lawrence 11
Medford 11
Florence 10
Singapore 9
Dakar 8
Serra 8
Dong Ket 6
Istanbul 6
Nanjing 5
Pisa 5
London 4
Redwood City 4
Shanghai 4
Shenyang 4
Tianjin 4
Tokyo 4
Brussels 3
Changsha 3
Dallas 3
Hebei 3
Lagos 3
Toronto 3
Buffalo 2
Düsseldorf 2
Frankfurt am Main 2
Fuzhou 2
Hefei 2
Jiaxing 2
Jinan 2
Kunming 2
Nanchang 2
Norwalk 2
Quanzhou 2
San Diego 2
San Jose 2
Siena 2
Warsaw 2
Washington 2
Baotou 1
Belize City 1
Cave Creek 1
Chongqing 1
Genova 1
Guangzhou 1
Helsinki 1
Izmir 1
Jacksonville 1
Jakarta 1
Los Angeles 1
Mcallen 1
Mexico City 1
Milan 1
Modesto 1
Nürnberg 1
Ogden 1
Olomouc 1
Phoenix 1
Pistoia 1
Quzhou 1
San Francisco 1
Seoul 1
Southwick 1
Strasbourg 1
Suffern 1
Tezze Sul Brenta 1
Vellore 1
Wuhan 1
Xian 1
Totale 878
Nome #
Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data 146
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties 142
Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results 116
AVOIDING CALINEURIN INHIBITORS IN THE EARLY POST OPERATIVE COURSE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 107
AVOIDING CALCINEURIN INHIBITORS IN THE EARLY POST-OPERATIVE COURSE IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 104
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: Preliminary results of the protect trial 101
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system 99
Polymorphism of Opioid Receptors μ1 in Highly Hypnotizable Subjects 87
TORQUETENOVIRUS VIREMIA KINETICS AS A NOVEL MARKER OF FUNCTIONAL IMMUNE DEFICIENCY IN SOLID ORGAN TRANSPLANTATION 86
CLINICAL IMPACT OF PREEXISTING AND DE NOVO ANTI-ENDOTHELIAL CELL ANTIBODIES DETECTED BY A NEW INDIRECT IMMUNOFLUORESCENCE ASSAY IN KIDNEY AND PANCREAS TRANSPLANTATION 85
CLINICAL IMPACT OF PREEXISTING AND DE NOVO ANTIENDOTHELIAL CELL ANTIBODIES DETECTED BY A NEW INDIRECT IMMUNOFLUORESCENCE ASSAY IN KIDNEY AND PANCREAS TRANSPLANTATION 79
Totale 1.152
Categoria #
all - tutte 3.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020103 0 0 0 0 16 23 15 11 15 7 13 3
2020/202160 8 2 2 3 7 4 3 4 6 3 3 15
2021/2022150 0 6 1 8 26 17 1 17 10 7 9 48
2022/2023228 16 43 20 14 30 31 1 18 43 0 12 0
2023/202477 9 9 8 3 7 21 8 0 1 0 2 9
2024/202553 2 12 0 26 13 0 0 0 0 0 0 0
Totale 1.152